144 related articles for article (PubMed ID: 3276823)
1. The characteristics and outcome of patients with late relapse acute myelogenous leukemia.
Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Freireich EJ
J Clin Oncol; 1988 Feb; 6(2):232-8. PubMed ID: 3276823
[TBL] [Abstract][Full Text] [Related]
2. Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Keating MJ; Kantarjian H; Smith TL; Estey E; Walters R; Andersson B; Beran M; McCredie KB; Freireich EJ
J Clin Oncol; 1989 Aug; 7(8):1071-80. PubMed ID: 2666590
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
[TBL] [Abstract][Full Text] [Related]
5. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia.
Schwartz RS; Mackintosh FR; Halpern J; Schrier SL; Greenberg PL
Cancer; 1984 Oct; 54(8):1672-81. PubMed ID: 6592033
[TBL] [Abstract][Full Text] [Related]
7. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
[TBL] [Abstract][Full Text] [Related]
8. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy.
Hiddemann W; Martin WR; Sauerland CM; Heinecke A; Büchner T
Leukemia; 1990 Mar; 4(3):184-8. PubMed ID: 2314117
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
[TBL] [Abstract][Full Text] [Related]
11. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
12. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
[TBL] [Abstract][Full Text] [Related]
13. Outcome of older patients with acute myeloid leukemia in first relapse.
Sarkozy C; Gardin C; Gachard N; Merabet F; Turlure P; Malfuson JV; Pautas C; Micol JB; Thomas X; Quesnel B; Celli-Lebras K; Preudhomme C; Terré C; Fenaux P; Chevret S; Castaigne S; Dombret H
Am J Hematol; 2013 Sep; 88(9):758-64. PubMed ID: 23749683
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
Pich A; Chiusa L; Audisio E; Marmont F
J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
17. Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia.
Stahnke K; Boos J; Bender-Götze C; Ritter J; Zimmermann M; Creutzig U
Leukemia; 1998 Oct; 12(10):1534-8. PubMed ID: 9766496
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
19. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
[TBL] [Abstract][Full Text] [Related]
20. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
Mortimer J; Blinder MA; Schulman S; Appelbaum FR; Buckner CD; Clift RA; Sanders JE; Storb R; Thomas ED
J Clin Oncol; 1989 Jan; 7(1):50-7. PubMed ID: 2642540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
